🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Vortioxetine

    Takeda

    Type2 Diabetes

    approved small molecule terminated

    1 trial

  2. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  3. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial

  4. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  5. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  6. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  7. Zhenyuan capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Coronary Heart Disease

    approved small molecule active

    1 trial

  8. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  9. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  10. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  11. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

  12. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  13. dabrafenib

    Novartis Pharmaceuticals

    Melanoma

    approved small molecule active

    1 trial

  14. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  15. dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  16. dupilumab

    Regeneron UK Limited

    Severe Atopic Dermatitis (AD)

    approved small molecule terminated

    1 trial

  17. gabapentin + tramadol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pain

    approved small molecule active

    1 trial

  18. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  19. handwashing

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Communicable Diseases

    approved other completed

    1 trial

  20. inotuzumab ozogamicin-dose level 2

    Pfizer

    Leukemia

    approved small molecule completed

    1 trial

  21. insulin detemir

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  22. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  23. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  24. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources